Social Icons

Saturday, August 25, 2012

Out of Patent Drugs could mean $170 billion loss for big pharma

Ateneo Professor on Entrepreneurship

This post is an invitation for subscription for private briefing - investment opportunity for only $5.00 per month

One of the opportunities is the expiry of drugs of large pharma.  The expiry would mean a potential loss of sales to the tune of $l70 billion.  For the pharmas to speed up the process, they will buy small pharma with blockbuster discoveries.  Would you what are those companies so that you can invest in them?

No comments:

Post a Comment